1. Home
  2. SER vs BDSX Comparison

SER vs BDSX Comparison

Compare SER & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$1.51

Market Cap

19.4M

Sector

Health Care

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$17.26

Market Cap

122.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SER
BDSX
Founded
2017
2005
Country
United States
United States
Employees
13
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.4M
122.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
SER
BDSX
Price
$1.51
$17.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$13.00
$32.50
AVG Volume (30 Days)
80.3K
153.6K
Earning Date
01-01-0001
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$88,499,000.00
Revenue This Year
$134.46
$23.35
Revenue Next Year
N/A
$19.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.08
52 Week Low
$1.42
$0.25
52 Week High
$7.92
$20.21

Technical Indicators

Market Signals
Indicator
SER
BDSX
Relative Strength Index (RSI) 36.51 62.47
Support Level N/A $6.33
Resistance Level $1.86 N/A
Average True Range (ATR) 0.12 1.84
MACD 0.02 0.20
Stochastic Oscillator 21.32 65.98

Price Performance

Historical Comparison
SER
BDSX

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: